The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 452.50
Bid: 445.00
Ask: 460.00
Change: 5.00 (1.12%)
Spread: 15.00 (3.371%)
Open: 447.50
High: 452.50
Low: 447.50
Prev. Close: 447.50
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disinfectant Demand Pushes Up Tristel's Interim Profit, Hikes Dividend

Mon, 22nd Feb 2021 10:59

(Alliance News) - Tristel PLC on Monday reported a higher half-year profit, with overseas revenue particularly high, as the pandemic lifted demand for disinfectants.

The company, which makes infection prevention and contamination control products, posted a GBP3.1 million pretax profit for the six months ended December 31, up 11% from GBP2.8 million the year before.

Revenue increased 15% to GBP16.8 million from GBP14.6 million, including an 8% rise in UK revenue thanks to an 18% rise in cash surface disinfection revenue to GBP1.5 million from GBP800,000.

Overseas revenue increased by 20% to GBP10.0 million from GBP8.3 million, including a 19% rise in Tristel medical device decontamination revenue to GBP8.7 million plus a 67% rise in cash surface disinfection revenue to GBP500,000.

"Tristel product sales in all countries have been adversely affected as patient examinations have been deferred. Cache product sales have been positively impacted because hospitals rushed to purchase any type of disinfectant. During the second half of 2020 this phenomenon came to an end and now we are observing a more considered approach to the selection of surface disinfectants," explained Chair Bruno Holthof.

The company lifted its interim dividend per share by 12% to 2.62 pence from 2.34p a share the year before.

Chief Executive Paul Swinney said: "The second half will be the third consecutive six-month period to be impacted by the pandemic. Unlike the previous two halves, we have started this one in lockdown in many of our key markets. Sales of our medical device disinfectants during the first seven weeks of 2021 are lower than budget due to the impact of Covid-19 on patient examinations. We are very confident that by the end of calendar 2021, the ENT, gynaecology, urology, cardiology, and ophthalmology departments where our products are used will have returned to pre-pandemic levels of activity. Whether this will happen in the UK and Europe before our June year-end is unclear at present.

"However, the growth prospects for the group are as strong as ever and we look to the future with confidence."

Shares in Tristel were up 0.1% at 600.55p in London on Monday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Oct 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
10 Oct 2014 16:14

MARKET COMMENT: UK Stocks Tumble On Eurozone, Ebola Concerns

Read more
10 Oct 2014 14:48

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
10 Oct 2014 05:26

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Oct 2014 15:14

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Oct 2014 05:26

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Oct 2014 14:58

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Oct 2014 05:26

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Oct 2014 15:05

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Oct 2014 05:21

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
6 Oct 2014 15:19

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
19 Aug 2014 08:54

Tristel Says Wipes Systems Leader In UK Ear, Nose And Throat Market

Read more
1 Aug 2014 14:19

Sector movers: Smith & Nephew lifts defensive healthcare stocks

The healthcare sector was the only category in positive territory on Friday as investors sought defensive stocks in the face of a wider market sell-off. Meanwhile, results from medical devices maker Smith & Nephew were also encouraging investors in the healthcare space after modestly beating foreca

Read more
28 Jul 2014 10:25

Tristel Profit To Be Ahead Of Expectations On Strong Second-Half

Read more
10 Jun 2014 11:38

London midday: UK stocks pull back from four-week high

- FTSE 100 retreats from highest close since May 14th - DAX, Dow and S&P 500 at record highs - Chinese CPI rises, UK production improves - BT falls as Sky unveils new sports channel techMARK 2,851.50 -0.20% FTSE 100 6,845.20 -0.43% FTSE 250 16,205.98 -0.08% UK stocks pulled back on Tuesday after t

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.